Edgewise Therapeutics, Inc. (EWTX) Tops Q1 EPS by 6c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
• Best Buy (BBY) PT Raised to $90 at UBS as Recovery Looks Broader, More Durable
• BofA sees mixed signals for European software from US SaaS